Cooper Investors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Sell |
414,162
-2,374
| -0.6% | -$85.5K | 2.71% | 12 |
|
|
2025
Q1 | $13M | Hold |
416,536
| – | – | 2.11% | 22 |
|
|
2024
Q4 | $10.6M | Buy |
416,536
+7,332
| +2% | +$187K | 1.67% | 26 |
|
|
2024
Q3 | $11.6M | Sell |
409,204
-1,980
| -0.5% | -$56K | 1.72% | 25 |
|
|
2024
Q2 | $10.8M | Hold |
411,184
| – | – | 1.65% | 23 |
|
|
2024
Q1 | $12.5M | Buy |
411,184
+18,390
| +5% | +$559K | 0.72% | 30 |
|
|
2023
Q4 | $11M | Buy |
392,794
+71,400
| +22% | +$2.01M | 0.66% | 30 |
|
|
2023
Q3 | $9.88M | Buy |
+321,394
| New | +$9.88M | 0.79% | 25 |
|
|
2023
Q1 | $11.5M | Sell |
320,264
-66,856
| -17% | -$2.41M | 0.98% | 22 |
|
|
2022
Q4 | $15.3M | Sell |
387,120
-1,594
| -0.4% | -$63K | 1.44% | 21 |
|
|
2022
Q3 | $15.6M | Buy |
388,714
+16,488
| +4% | +$662K | 1.48% | 21 |
|
|
2022
Q2 | $15.6M | Sell |
372,226
-48,855
| -12% | -$2.05M | 1.36% | 24 |
|
|
2022
Q1 | $16.4M | Buy |
421,081
+7,473
| +2% | +$291K | 1.15% | 22 |
|
|
2021
Q4 | $16.5M | Sell |
413,608
-529,769
| -56% | -$21.1M | 1.04% | 23 |
|
|
2021
Q3 | $34.1M | Buy |
943,377
+342,876
| +57% | +$12.4M | 2.26% | 19 |
|
|
2021
Q2 | $24.6M | Buy |
600,501
+422,767
| +238% | +$17.3M | 1.61% | 26 |
|
|
2021
Q1 | $7.75M | Buy |
177,734
+148,860
| +516% | +$6.49M | 0.58% | 33 |
|
|
2020
Q4 | $1.45M | Buy |
+28,874
| New | +$1.45M | 0.12% | 41 |
|